Intraspinal use of morphineGAUDETTE, Kathryn E; WEAVER, S. Jay.The Annals of pharmacotherapy. 2003, Vol 37, Num 7-8, pp 1132-1135, issn 1060-0280, 4 p.Article

Do sex differences exist in opioid analgesia? A systematic review and meta-analysis of human experimental and clinical studiesNIESTERS, Marieke; DAHAN, Albert; KEST, Benjamin et al.Pain (Amsterdam). 2010, Vol 151, Num 1, pp 61-68, issn 0304-3959, 8 p.Article

Endogenous opioids and epinephrine in nitroglycerin provocation tilt test in patients with neurally mediated syncopeTAKASE, Bonpei; MATSUSHIMA, Yoshihiro; UMEDA, Eiichiro et al.Japanese heart journal. 2003, Vol 44, Num 4, pp 493-503, issn 0021-4868, 11 p.Article

Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female ratsCRAFT, R. M; MCNIEL, D. M.Pharmacology, biochemistry and behavior. 2003, Vol 75, Num 1, pp 235-245, issn 0091-3057, 11 p.Article

The Pain Pen for breakthrough cancer pain : A promising treatmentENTING, Roelien H; MUCCHIANO, Carlo; OLDENMENGER, Wendy H et al.Journal of pain and symptom management. 2005, Vol 29, Num 2, pp 213-217, issn 0885-3924, 5 p.Article

Non-Analgesic Effects of Opioids: Factors Relevant to Opioid Abuse and Abuse-Deterrent Formulations : Non-Analgesic Effects of OpioidsPERGOLIZZI, Joseph V; RAFFA, Robert B; PERGOLIZZI, Jason S et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 37, pp 6109-6115, issn 1381-6128, 7 p.Article

Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centersLÖTSCH, Jörn; VON HENTIG, Nils; FREYNHAGEN, Rainer et al.Pharmacogenetics and genomics (Print). 2009, Vol 19, Num 6, pp 429-436, issn 1744-6872, 8 p.Article

Structure-activity relationship of rubiscolins as δ opioid peptidesSHUZHANG YANG; SONODA, Soushi; LIPING CHEN et al.Peptides (New York, NY. 1980). 2003, Vol 24, Num 4, pp 503-508, issn 0196-9781, 6 p.Article

Highly potent fluorescent analogues of the opioid peptide [Dmt¹]DALDABEREZOWSKA, Irena; CHUNG, Nga N; LEMIEUX, Carole et al.Peptides (New York, NY. 1980). 2003, Vol 24, Num 8, pp 1195-1200, issn 0196-9781, 6 p.Article

Opioid peptides in cancerFICHNA, Jakub; JANECKA, Anna.Cancer metastasis reviews. 2004, Vol 23, Num 3-4, pp 351-366, issn 0167-7659, 16 p.Article

A tribute to the late Hans W. Kosterlitz : Ploughing the lone furrowLEES, G. M.Canadian journal of physiology and pharmacology. 1998, Vol 76, Num 3, pp 244-251, issn 0008-4212Article

[³H]Alvimopan binding to the μ opioid receptor : Comparative binding kinetics of opioid antagonistsCASSEL, Joel A; DAUBERT, Jeffrey D; DEHAVEN, Robert N et al.European journal of pharmacology. 2005, Vol 520, Num 1-3, pp 29-36, issn 0014-2999, 8 p.Article

Schild (apparent pA₂) analysis of a κ-opioid antagonist in PlanariaRAFFA, Robert B; BARON, David A; TALLARIDA, Ronald J et al.European journal of pharmacology. 2006, Vol 540, Num 1-3, pp 200-201, issn 0014-2999, 2 p.Article

Endogenous opiates and behavior : 2004BODNAR, Richard J; KLEIN, Gad E.Peptides (New York, NY. 1980). 2005, Vol 26, Num 12, pp 2629-2711, issn 0196-9781, 83 p.Article

National Trends in the Office-Based Prescription of Schedule II OpioidsOLFSON, Mark; SHUAI WANG; IZA, Miren et al.The Journal of clinical psychiatry. 2013, Vol 74, Num 9, pp 933-940, issn 0160-6689, 8 p.Article

BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonismHUSBANDS, Stephen M; NEILAN, Claire L; BROADBEAR, Jillian et al.European journal of pharmacology. 2005, Vol 509, Num 2-3, pp 117-125, issn 0014-2999, 9 p.Article

Opioid Receptors and Their Ligands in the Musculoskeletal System and Relevance for Pain Control : Current Perspectives and Challenges in Design, Chemistry and Pharmacology of OpioidsSPETEA, Mariana.Current pharmaceutical design (Print). 2013, Vol 19, Num 42, pp 7382-7390, issn 1381-6128, 9 p.Article

75 years of opioid research : the exciting but vain quest for the Holy GrailCORBETT, Alistair D; HENDERSON, Graeme; MCKNIGHT, Alexander T et al.British journal of pharmacology. 2006, Vol 147, issn 0007-1188, S153-S162, SUP1Article

Tritiated Opioid Receptor Ligands as Radiotracers : Current Perspectives and Challenges in Design, Chemistry and Pharmacology of OpioidsTOTH, Géza; MALLAREDDY, Jayapal Reddy.Current pharmaceutical design (Print). 2013, Vol 19, Num 42, pp 7461-7472, issn 1381-6128, 12 p.Article

Non-Analgesic Effects of Opioids: Cardiovascular Effects of Opioids and their Receptor Systems : Non-Analgesic Effects of OpioidsHEADRICK, John P; PEPE, Salvatore; PEART, Jason N et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 37, pp 6090-6100, issn 1381-6128, 11 p.Article

Targeting of opioid-producing leukocytes for pain controlMACHELSKA, Halina.Neuropeptides (Edinburgh). 2007, Vol 41, Num 6, pp 355-363, issn 0143-4179, 9 p.Article

Increased affinity and selectivity of enkephalin tripeptide (Tyr-D-Ala-Gly) dimersLUTZ, R. A; CRUCIANI, R. A; SHIMOHIGASHI, Y et al.European journal of pharmacology. 1985, Vol 111, Num 2, pp 257-261, issn 0014-2999Article

Enkephalin degradation by enkephalinergic neuroblastoma cells: involvement of angiotensin-converting-enzymePALENKER, J; LENTZEN, H; BRANDT, U et al.Naunyn-Schmiedeberg's archives of pharmacology. 1984, Vol 325, Num 3, pp 214-217, issn 0028-1298Article

Elevation of serum corticosterone in rats by bremazocine, a κ-opioid agonistFULLER, R. W; LEANDER, J. D.Journal of pharmacy and pharmacology. 1984, Vol 36, Num 5, pp 345-346, issn 0022-3573Article

Presence of immunoreactive dynorphin in human cerebrospinal fluidTOZAWA, F; SUDA, T; TACHIBANA, S et al.Life sciences (1973). 1984, Vol 35, Num 16, pp 1633-1637, issn 0024-3205Article